Multi-Chiral Centre Pharmaceutical Profiling
Researchers have developed a new method of profiling compounds with multiple chiral centres using a LC–mLC approach.
coreDESIGN/stock.adobe.com
Researchers from Genentech Inc., have developed a new method of profiling compounds with multiple chiral centres using a two dimensional multicolumn liquid chromatographic (LC–mLC) approach (1).
A vast increase in drug candidates with multiple chiral centers is posing a significant challenge to analysts with the traditional chiral high performance liquid chromatography (HPLC) methods requiring a gruelling development process and still not guaranteeing a sufficient resolution for all stereoisomers. However, the precise and accurate analysis of all stereoisomers is essential as despite having the same chemical composition and connectivity, chiral stereoisomers can present vastly different pharmacological properties such as increased toxicity, differing pharmacokinetics, or even a different metabolic process. It is therefore essential that all stereoisomers of a drug compound are analysed and controlled to ensure the safety of those taking the medicines. To address this issue, researchers developed a LC–mLC 2D-LC approach which used multiple chiral stationary phases and mobile phases in the second dimension to resolve stereoisomers of compounds with multiple chiral centers and the related achiral impurities. The first dimension consists of a short achiral HPLC method to separate diastereomers and other achiral impurities, and the second dimension enables different chiral columns and different mobile phases to be used on each coeluted peak from the first dimension for maximum resolution. Essentially breaking down the complex multiple-chiral-center separations into simple individual separations.
The method was successfully employed to separate eight stereoisomers of a pharmaceutical compound with three chiral centers with a total method development time of around two hours and an analysis time of 24 min, which include column equilibration time.
References
- Lin et al., J. Chroma. A. 1620, 460987 (2020).
Measuring Vitamin K1 Concentrations in Dogs with Chronic Enteropathy Using LC–MS/MS
May 14th 2025A joint study between the University of Tennessee (Knoxville, Tennessee) and the University of Pennsylvania School of Veterinary Medicine (Philadelphia, Pennsylvania) compared directly measured vitamin K1 (vitK1) concentrations in healthy dogs and dogs with chronic enteropathy (CE) using liquid chromatography tandem mass spectrometry (LC–MS/MS); they also investigated whether supplementation of vitK1 in dogs with CE would significantly increase vitK1 concentrations.
HPLC 2025 Preview: Fundamentally Speaking (Part 2)
May 14th 2025Michael Lämmerhofer from the Institute of Pharmaceutical Sciences, University of Tübingen, Germany, spoke to JFK Huber Lecture Award winner of 2024 Torgny Fornstedt, professor in analytical chemistry and leader of the Fundamental Separation Science Group, Karlstad University, Sweden, about his pioneering work in high performance liquid chromatography (HPLC) with a focus on fundamentals, ion-pair chromatography, and oligonucleotide applications.
